Human AML cell lines
| Name | FAB | Description | Cytogenetics |
| HL60 | M2 | Progranulocytic AML without features of APML | der(5)t(15;17), but no RARa rearrangement |
| NB4 | M3 | Relapsed APML | t(15;17) PML-RARa |
| ML1 | M4 | Secondary AML with MLL rearrangement | t(6;11) MLL-AF6 |
| THP1 | M5 | Infant AML with MLL rearrangement | t(9;11) MLL |
| U937 | M5 | Monocyte-like histiocytic sarcoma with CD13/C15/CD33 expression | t(10;11), t(1;5) |
| KG1 | M6 | Erythroleukemia | |
| KU812 | CML-B | CML blast crisis, features of basophils | t(9;22) BCR-ABL1 |
| K562 | CML-B | CML blast crisis, undifferentiated granulocytic with erythroid features | t(9;22) BCR-ABL1 |
| Name | FAB | Description | Cytogenetics |
| HL60 | M2 | Progranulocytic AML without features of APML | der(5)t(15;17), but no RARa rearrangement |
| NB4 | M3 | Relapsed APML | t(15;17) PML-RARa |
| ML1 | M4 | Secondary AML with MLL rearrangement | t(6;11) MLL-AF6 |
| THP1 | M5 | Infant AML with MLL rearrangement | t(9;11) MLL |
| U937 | M5 | Monocyte-like histiocytic sarcoma with CD13/C15/CD33 expression | t(10;11), t(1;5) |
| KG1 | M6 | Erythroleukemia | |
| KU812 | CML-B | CML blast crisis, features of basophils | t(9;22) BCR-ABL1 |
| K562 | CML-B | CML blast crisis, undifferentiated granulocytic with erythroid features | t(9;22) BCR-ABL1 |